Parkman Healthcare Partners LLC Novavax Inc Transaction History

Parkman Healthcare Partners LLC

  • $678 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$112.98 - $319.93 $3.9 Million - $11 Million
-34,498 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$78.74 - $139.5 $1.34 Million - $2.37 Million
16,998 Added 97.13%
34,498 $3.85 Million
Q3 2020

Nov 13, 2020
SELL
$79.44 - $178.51 $1.79 Million - $4.02 Million
-22,500 Reduced 56.25%
17,500 $1.9 Million
Q2 2020

Aug 13, 2020
BUY
$13.86 - $83.61 $554,400 - $3.34 Million
40,000 New
40,000 $3.33 Million

Others Institutions Holding NVAX

# of Institutions
286
Shares Held
84.8M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $713M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email